Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
Daniel Edward Robert Beck,1 Karim El-Assal,1 Ken McGarry,2 Nicholas Kloster Wride1
1Sunderland Eye Infirmary, 2Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK
We read with interest the article by Negrete et al.1 A recent study performed at our unit found similar results on conducting a review of tolerance to preservative-free latanoprost (Monopost) in patients who were unable to tolerate preserved formulae, and we would like to take the opportunity to share the results with you.
View the original paper by Negrete and colleagues.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]